Showing posts with label cancer cure. Show all posts
Showing posts with label cancer cure. Show all posts

Saturday, November 6, 2010

Prevention is the best solution! Please people let prevention save you from suffering!

It is impossible to overemphasize the value of prevention. There is no doubt that this is a complex and polluted world and sometimes ailments can not be prevented or are genetic. But that is more rare than you might believe and the fact is that we MUST do whatever we can to act intelligently so we can prevent the Cancer diagnosis that many people are receiving these days.

Cancer is not good. But it can be a sign that lifestyle needs to change and if heeded can lead to a transformational experience and bring enlightenment. The problem with Cancer is the diagnosis itself and the treatments and the lack of quality of life that can follow. Below is a NY Times article on the Side Effects of Radiation that were not well understood by the patient.

If you want to cure yourself of cancer, begin to research the thousands of cases of people who have cured their cancer through raw foods. The best place to cure cancer in the United States is Hippocrates Institute in Palm Beach, Fl.

Prevent Cancer by eating lots of well washed fruits, and vegetable based foods. Eat as much Raw Vegan Food as humanly possible... enjoying the blessings of Fruit that God put on this planet for us. Drink Green Liquids like Spirulina or A.F.A. Blue Green Algae (best) and exercise everyday. Exercise everyday with Yoga if possible, eat according to your primate biology (you are not an omnivore and certainly not a carnivore), and become aware of patterns of self judgment and self criticism and transcend with waves of gratitude and surrender.

This is the formula for the prevention of almost all disease. To the degree that our actions will assist us in prevention, these are the actions to take. Be smart, be aware and then do what you want! It is your life... just realize that health is the only WEALTH.

fb

NY Times 10/06/10

Wiry, fair-haired and in his 60s, the patient had received a prostate cancer diagnosis a year earlier. When his doctors told him that surgery and radiation therapy were equally effective and that it was up to him to decide, he chose radiation with little hesitation.

But one afternoon a month after completing his treatment, the patient was shocked to see red urine collecting in the urinal. After his doctors performed a series of tests and bladder irrigations through a pencil-size catheter, he learned that the bleeding was a complication of the radiation treatment.

He recalled briefly hearing about this side effect three months earlier, but none of the reports he had been given or collected mentioned it, and once he had recovered from the angst of the emergency room and the doctor’s office visits and the discomfort of the clinical work-up, he didn’t give it more thought — until a few weeks later, when he started bleeding again.

By the time I met him, he was in the middle of his third visit to the hospital. “I feel like I’m tied to this place,” he said. He showed me a plastic jug partly filled with urine the color of fruit punch, and he described a post-treatment life marked by fear of going to the bathroom and discovering blood. “If I had known that my life would be like this after radiation,” he sighed, “I would have chosen the surgery.”

Whether conducted at a laboratory bench or in clinical trials, medical research has long been driven by a single overriding goal — the need to find a cure. Usually referred to more modestly as a search for “the most effective treatment,” this standard has served as both a barometer of success and a major criterion for funding. Most published studies are marked by a preponderance of data documenting even minor blips in laboratory values or changes in the size of a spot of cancer or area of heart muscle damage on specialized X-rays. Some studies bolster the apparent success of their results with additional data on societal effects like treatment costs or numbers of workdays missed.

Few studies, however, focus on the patient experience.

The result of all this emphasis on cure has been a nearly embarrassing richness of choice for patients with diabetes, heart disease, H.I.V. infections and even some cancers. The increasingly sophisticated treatment regimens that now make up medicine’s armamentarium have transformed once life-threatening diseases into chronic ones, but in the process have given rise to a group of individuals who are caught in the unenviable position of living with an illness that never quite goes away. No longer forced to make once-in-a-lifetime life-or-death treatment decisions, they instead struggle each day with the side effects of the very treatments that keep them alive.

For many of these patients, the most important question becomes not “What treatment will allow me to live the longest?” but rather “Which treatment can I live with?”

Now, according to a paper published last month in the policy journal Health Affairs, the Patient-Centered Outcomes Research Institute, a new initiative mandated by the federal health care overhaul, may offer a chance to alter the prevailing winds of medical research so the needs of this growing segment of the patient population are addressed. With a 21-member board made up of individuals from both the public and private sectors, the institute has a mandate to set the agenda for research comparing treatments for common diseases and to finance the most important studies. But according to the paper’s authors, the potential of such an enterprise will be fully realized only if the institute supports initiatives and strategies that place the patient experience not only front and center in research but also smack in the middle of the medical mainstream.

“To some extent, we’ve conquered death,” said Dr. Albert W. Wu, lead author and a general internist and professor of health policy and management at the Johns Hopkins Bloomberg School of Public Health in Baltimore. “Now we have people living with chronic illnesses, and how they experience quality of life every day has become an important part of how they are doing and whether the treatments are worthwhile.”

To effectively capture the patient perspective, Dr. Wu and his co-authors propose making patient-reported outcomes a more routine part of clinical studies and practice and administrative data collection, in some cases requiring the information for reimbursement. For several months now, they have been incorporating data about patient experiences into routine medical practice at Johns Hopkins. Using a dedicated portal called PatientViewpoint.org, patients can, at the suggestion of their physicians, fill out surveys about their energy levels, social functioning, mental health, nausea and pain. The information is then handled like more traditional clinical testing; access is reserved for the patients themselves and their doctors.

Currently, the site is open only to patients diagnosed with breast or prostate cancer, but Dr. Wu and his colleagues hope that eventually all doctors will be able to order patient surveys that measure experiences like levels of pain, physical functioning or depression, proactively identifying results that are high or low, then reviewing those results with patients. And despite initial concerns that patients might feel overburdened by the questionnaires, most have been enthusiastic.

“Patients want to have more conversations with their physicians and other providers about these kinds of issues,” Dr. Wu said. “Sometimes it’s difficult to cover all this information during the medical encounter, and these surveys may be another opportunity to do that.”

Not all clinicians or researchers, however, are eager to embrace patient-reported outcomes. Many have never received training in the research methods involved and are skeptical about the value of a discipline or drill that is unfamiliar. “This is considered to be squishy, soft stuff,” Dr. Wu said. “It’s still not something you can order on a laboratory slip.”

Nonetheless, Dr. Wu is hopeful that the new Patient-Centered Outcomes Research Institute will provide more direction to all researchers, while establishing new and more comprehensive standards that require patient-reported and quality-of-life outcomes. “I think we have a real opportunity right now, and this institute has great potential to be a positive force in understanding how treatments work and what’s effective and for whom,” he said.

But he also cautioned: “We have to remember to include the patients. We have to include their perspective if we want to come up with evidence that they can really use to make better decisions for themselves about treatment and care.”

Tuesday, July 20, 2010

Breast Cancer False Positives

One of the most interesting parts of this article from the NY Times yesterday is where it is admitted that they have a very hard time trying to figure out if a cluster of cells in malignant or benign. It is very interesting because it may be that at that point the cluster of cells has not decided. There are so many places along the way that Cancer cell formation can be mitigated and possibly reversed. Understanding what foods promote tumor growth and which foods reverse the trend is invaluable information. Cancer is not a big deal necessarily. It becomes a bigger deal because we continue to 'feed it'.

Nearly a year earlier, in 2007, a pathologist at a small hospital in Cheboygan, Mich., had found the earliest stage of breast cancer from a biopsy. Extensive surgery followed, leaving Ms. Long’s right breast missing a golf-ball-size chunk.

Now she was being told the pathologist had made a mistake. Her new doctor was certain she never had the disease, called ductal carcinoma in situ, or D.C.I.S. It had all been unnecessary — the surgery, the radiation, the drugs and, worst of all, the fear.

“Psychologically, it’s horrible,” Ms. Long said. “I never should have had to go through what I did.”

Like most women, Ms. Long had regarded the breast biopsy as the gold standard, an infallible way to identify cancer. “I thought it was pretty cut and dried,” said Ms. Long, who is a registered nurse.

As it turns out, diagnosing the earliest stage of breast cancer can be surprisingly difficult, prone to both outright error and case-by-case disagreement over whether a cluster of cells is benign or malignant, according to an examination of breast cancer cases by The New York Times.

Advances in mammography and other imaging technology over the past 30 years have meant that pathologists must render opinions on ever smaller breast lesions, some the size of a few grains of salt. Discerning the difference between some benign lesions and early stage breast cancer is a particularly challenging area of pathology, according to medical records and interviews with doctors and patients.

Diagnosing D.C.I.S. “is a 30-year history of confusion, differences of opinion and under- and overtreatment,” said Dr. Shahla Masood, the head of pathology at the University of Florida College of Medicine in Jacksonville. “There are studies that show that diagnosing these borderline breast lesions occasionally comes down to the flip of a coin.”

There is an increasing recognition of the problems, and the federal government is now financing a nationwide study of variations in breast pathology, based on concerns that 17 percent of D.C.I.S. cases identified by a commonly used needle biopsy may be misdiagnosed. Despite this, there are no mandated diagnostic standards or requirements that pathologists performing the work have any specialized expertise, meaning that the chances of getting an accurate diagnosis vary from hospital to hospital.

Dr. Linh Vi, the pathologist at Cheboygan Memorial Hospital who diagnosed D.C.I.S. in Ms. Long, was not board certified and has said he reads about 50 breast biopsies a year, far short of the experience that leading pathologists say is needed in dealing with the nuances of difficult breast cancer cases. In responding to a lawsuit brought by Ms. Long, Dr. Vi maintains that she had cancer and that two board-certified pathologists at a neighboring hospital concurred with his diagnosis.

Yet several leading experts who reviewed Ms. Long’s case disagreed, with one saying flatly that her local pathologists “blew the diagnosis.”

The questions that often surround D.C.I.S. diagnoses take on added significance when combined with criticism that it is both overdiagnosed and overtreated in the United States — concerns that helped fuel the recent controversy over the routine use of mammograms for women in their 40s.

The United States Preventive Services Task Force, an independent panel that issues guidelines on cancer screening, found last November that the downside of routine annual mammograms for younger women might offset the benefits of early detection. The panel specifically referred to overdiagnosis of D.C.I.S., as well as benign but atypical breast lesions that left undetected would never cause problems.

D.C.I.S., which is also called Stage 0 or noninvasive cancer, was a rare diagnosis before mammograms began to be widely used in the 1980s. Until then, breast pathology typically involved reading tissue from palpable lumps. The diagnoses — usually invasive cancer, a benign fibroid tumor or a cyst — were often obvious.

Friday, February 27, 2009

40% British Cancers Preventable and American Cancer Association said cancer prevention would be profound

The Daily Telegraph in London reported on research which indicates that 40% of Cancers in the UK is preventable.

The American Cancer Association said last week that over 35 % of Cancer cases in the United States could be avoided with change in Diet, Exercise, and Alcohol.

As the Obama administration is interested in Preventative Health as a means to mitigate the Health Care epidemic of costs and lack of results, I submit an answer.

As i have written about in my book, A Clear and Definite Path, the key to health is the combination of Eating Smart and Exercising Smart, and doing both as a lifestyle not a diet. I have been teaching and coaching this subject for 10 years and have seen result after result of people who have started in deep pain and ill health, and brought them to a place of pain free and healthier overall condition.

We need to put all of our intention and attention towards Prevention! Prevention of obesity in Childhood, Prevention of Cancer, Prevention of Heart Disease. Prevention is always better than cure! I can handle any study that somebody wants to fund or support demonstrating the relationship between Yoga, Smart Eating and Disease Prevention.

I have already designed such a study, and i will be forwarding this email to President Obama as well. We will see how serious people are about prevention of Disease and lowering health care costs on the both the front and back end substantially. Think of all the money that could be saved if people were not getting the kind of diseases with the kind of frequency.

It has long been obvious that smarter decisions effect things. What is interesting about this week is that the big research forces and cancer organizations are clearly explaining that the Triumverate of Eating Smart, Exercising Daily and reduce Alcohol can and will PREVENT CANCER. It is noteworthy that they are drawing this conclusion and hopefully the skeptical will now see the the light. Prevention is better than Cure!

The Fred Busch Program that i put my students on does exactly this! It creates an environment for prevention of problems, or alleviates already existing ones, within a spiritual context of realizing your true nature and Higher Self.

The Fred Busch program is specifically designed to Prevent Cancer.

Friday, October 24, 2008

Modern Medicine would rather manage disease than cure it.

It is far more profitable for Medicine to manage a disease than it is to prevent it or cure it. This is why Cancer treatment has become what it is today. I don't like to infer negative plots but this one is clear as day. They string people along with the treatments that take a long time to kill but that cost a lot of money. While on chemotherapy they demand that people eat twinkies and other garbage food so that the body can not resist the chemotherapy. There is little logic in the approach but there sure are billions of dollars going into the medical establishments pockets. Prevention is always better than cure! There is a cure for cancer. Cancer can be cured with the perfect combination of fasting, eating perfectly, meditation, rest, and grace. People like Brian Clemens at the Hippocrates Institute have been doing it for years. May God bless them!
My book will also help... go to www.fredbusch.com and check it out.